These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 11207636)

  • 1. Autoimmune polyendocrine syndrome type 1 (APS I) in Norway.
    Myhre AG; Halonen M; Eskelin P; Ekwall O; Hedstrand H; Rorsman F; Kämpe O; Husebye ES
    Clin Endocrinol (Oxf); 2001 Feb; 54(2):211-7. PubMed ID: 11207636
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Autoimmune polyendocrine syndrome type 1 in Norway: phenotypic variation, autoantibodies, and novel mutations in the autoimmune regulator gene.
    Wolff AS; Erichsen MM; Meager A; Magitta NF; Myhre AG; Bollerslev J; Fougner KJ; Lima K; Knappskog PM; Husebye ES
    J Clin Endocrinol Metab; 2007 Feb; 92(2):595-603. PubMed ID: 17118990
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Premature ovarian failure in patients with autoimmune Addison's disease: clinical, genetic, and immunological evaluation.
    Reato G; Morlin L; Chen S; Furmaniak J; Smith BR; Masiero S; Albergoni MP; Cervato S; Zanchetta R; Betterle C
    J Clin Endocrinol Metab; 2011 Aug; 96(8):E1255-61. PubMed ID: 21677034
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autoantibodies to steroidogenic enzymes in autoimmune polyglandular syndrome, Addison's disease, and premature ovarian failure.
    Chen S; Sawicka J; Betterle C; Powell M; Prentice L; Volpato M; Rees Smith B; Furmaniak J
    J Clin Endocrinol Metab; 1996 May; 81(5):1871-6. PubMed ID: 8626850
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expanding the Phenotypic and Genotypic Landscape of Autoimmune Polyendocrine Syndrome Type 1.
    Orlova EM; Sozaeva LS; Kareva MA; Oftedal BE; Wolff ASB; Breivik L; Zakharova EY; Ivanova ON; Kämpe O; Dedov II; Knappskog PM; Peterkova VA; Husebye ES
    J Clin Endocrinol Metab; 2017 Sep; 102(9):3546-3556. PubMed ID: 28911151
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autoimmune polyendocrine syndrome type I in Slovakia: relevance of screening patients with autoimmune Addison's disease.
    F Magitta N; Pura M; S Bøe Wolff A; Vanuga P; Meager A; M Knappskog P; Husebye ES
    Eur J Endocrinol; 2008 May; 158(5):705-9. PubMed ID: 18426830
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autoantibodies linked to autoimmune polyendocrine syndrome type I are prevalent in Down syndrome.
    Söderbergh A; Gustafsson J; Ekwall O; Hallgren A; Nilsson T; Kämpe O; Rorsman F; Annerén G
    Acta Paediatr; 2006 Dec; 95(12):1657-60. PubMed ID: 17129978
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutational analysis of the autoimmune regulator (AIRE) gene in sporadic autoimmune Addison's disease can reveal patients with unidentified autoimmune polyendocrine syndrome type I.
    Bøe AS; Knappskog PM; Myhre AG; Sørheim JI; Husebye ES
    Eur J Endocrinol; 2002 Apr; 146(4):519-22. PubMed ID: 11916620
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autoantibodies against type I interferons as an additional diagnostic criterion for autoimmune polyendocrine syndrome type I.
    Meloni A; Furcas M; Cetani F; Marcocci C; Falorni A; Perniola R; Pura M; Bøe Wolff AS; Husebye ES; Lilic D; Ryan KR; Gennery AR; Cant AJ; Abinun M; Spickett GP; Arkwright PD; Denning D; Costigan C; Dominguez M; McConnell V; Willcox N; Meager A
    J Clin Endocrinol Metab; 2008 Nov; 93(11):4389-97. PubMed ID: 18728167
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-interferon autoantibodies in autoimmune polyendocrinopathy syndrome type 1.
    Meager A; Visvalingam K; Peterson P; Möll K; Murumägi A; Krohn K; Eskelin P; Perheentupa J; Husebye E; Kadota Y; Willcox N
    PLoS Med; 2006 Jul; 3(7):e289. PubMed ID: 16784312
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autoimmune polyglandular syndrome type 1 in Russian patients: clinical variants and autoimmune regulator mutations.
    Orlova EM; Bukina AM; Kuznetsova ES; Kareva MA; Zakharova EU; Peterkova VA; Dedov II
    Horm Res Paediatr; 2010; 73(6):449-57. PubMed ID: 20407228
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autoantibodies to adrenal cytochrome P450 antigens in isolated Addison's disease and autoimmune polyendocrine syndrome type II.
    Seissler J; Schott M; Steinbrenner H; Peterson P; Scherbaum WA
    Exp Clin Endocrinol Diabetes; 1999; 107(3):208-13. PubMed ID: 10376448
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autoantibodies against aromatic L-amino acid decarboxylase identifies a subgroup of patients with Addison's disease.
    Söderbergh A; Rorsman F; Halonen M; Ekwall O; Björses P; Kämpe O; Husebye ES
    J Clin Endocrinol Metab; 2000 Jan; 85(1):460-3. PubMed ID: 10634424
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A new mutation site in the AIRE gene causes autoimmune polyendocrine syndrome type 1.
    Zhu W; Hu Z; Liao X; Chen X; Huang W; Zhong Y; Zeng Z
    Immunogenetics; 2017 Oct; 69(10):643-651. PubMed ID: 28540407
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of autoantibodies to interferon-ω in patients with autoimmune polyendocrine syndrome type 1: using a new immunoprecipitation assay.
    Larosa MDP; Mackenzie R; Burne P; Garelli S; Barollo S; Masiero S; Rubin B; Chen S; Furmaniak J; Betterle C; Smith BR
    Clin Chem Lab Med; 2017 Jun; 55(7):1003-1012. PubMed ID: 28099118
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Longitudinal Follow-up of Autoimmune Polyendocrine Syndrome Type 1.
    Bruserud Ø; Oftedal BE; Landegren N; Erichsen MM; Bratland E; Lima K; Jørgensen AP; Myhre AG; Svartberg J; Fougner KJ; Bakke Å; Nedrebø BG; Mella B; Breivik L; Viken MK; Knappskog PM; Marthinussen MC; Løvås K; Kämpe O; Wolff AB; Husebye ES
    J Clin Endocrinol Metab; 2016 Aug; 101(8):2975-83. PubMed ID: 27253668
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autoimmune polyendocrine syndrome type 1: an Italian survey on 158 patients.
    Garelli S; Dalla Costa M; Sabbadin C; Barollo S; Rubin B; Scarpa R; Masiero S; Fierabracci A; Bizzarri C; Crinò A; Cappa M; Valenzise M; Meloni A; De Bellis AM; Giordano C; Presotto F; Perniola R; Capalbo D; Salerno MC; Stigliano A; Radetti G; Camozzi V; Greggio NA; Bogazzi F; Chiodini I; Pagotto U; Black SK; Chen S; Rees Smith B; Furmaniak J; Weber G; Pigliaru F; De Sanctis L; Scaroni C; Betterle C
    J Endocrinol Invest; 2021 Nov; 44(11):2493-2510. PubMed ID: 34003463
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical and serologic parallels to APS-I in patients with thymomas and autoantigen transcripts in their tumors.
    Wolff AS; Kärner J; Owe JF; Oftedal BE; Gilhus NE; Erichsen MM; Kämpe O; Meager A; Peterson P; Kisand K; Willcox N; Husebye ES
    J Immunol; 2014 Oct; 193(8):3880-90. PubMed ID: 25230752
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autoantibodies against aromatic L-amino acid decarboxylase in autoimmune polyendocrine syndrome type I.
    Husebye ES; Gebre-Medhin G; Tuomi T; Perheentupa J; Landin-Olsson M; Gustafsson J; Rorsman F; Kämpe O
    J Clin Endocrinol Metab; 1997 Jan; 82(1):147-50. PubMed ID: 8989249
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autoantibodies to human tryptophan hydroxylase and aromatic L-amino acid decarboxylase.
    Dal Pra C; Chen S; Betterle C; Zanchetta R; McGrath V; Furmaniak J; Rees Smith B
    Eur J Endocrinol; 2004 Mar; 150(3):313-21. PubMed ID: 15012616
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.